In the PAH model, glycogen synthesis was attenuated via the increased expression of glycogen synthase kinase-3β (GSK3β), which downregulates glycogen synthesis by inhibiting the glycogen synthase (Figure 4A). Here, GSK3B is linked to pulmonary arterial hypertension.